Navigation Links
Ratcliff Adds Architect John Sealander to Healthcare Practice Group
Date:8/6/2009

969) from the University of California, Berkeley.

About Ratcliff

Headquartered in Emeryville, California, Ratcliff is the winner of the 2005 Firm of the Year Award from the American Institute of Architects-California Council. The third-generation architectural, planning and interiors firm employs a staff of 83 design professionals and is dedicated to designing sustainable structures in healthy balance with time, purpose and place. Ratcliff's list of representative health care clients includes John Muir Medical Center, ValleyCare Health System, and Kaiser Permanente. The Emeryville, Calif., firm is recognized as one of Interior Design magazine's Top 40 Healthcare Design Firms in the United States. Visit http://www.ratcliffarch.com for more information.


'/>"/>
SOURCE Ratcliff
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ratcliff Promotes Jorge Burbano to Senior Associate; Tess Kavanagh and Tony Keung to Associate
2. Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus
3. Kornberg Associates Architects Selected to Develop Design for New Stanford University Imaging Center
4. Kornberg Associates Architects Selected to Design Research Areas of Malaysia Genome Institute
5. Kornberg Associates Architects Opens Tokyo Office
6. First 3-D processor runs at 1.4 Ghz on new architecture
7. Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
8. PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
9. Free Webinar on Safer Clinical Hand-Offs Offered by Compirion Healthcare
10. iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers
11. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...NA, Austria, November 19 AFFiRiS A...e product candidate at an unexpectedly early,stage...nned to enter into,Phase II clinical trial early i...ollows the completion of two Phase I trials with t... fast decision on the first interim,analysis of th...
(Date:11/18/2009)...onal Institute of Standards and Technology (NIST) ...method for detecting and measuring elusive hazards...e spoilage in food or pesticides distributed in so...sensitive than conventional techniques for detecti...water molecules, having distinct electrically posi...
(Date:11/18/2009)...agine a polka-dotted postage stamp that can sniff ...nging colors. , As reported in the Sept. 13 issu...ck and his team at the University of Illinois have...ction of toxic industrial chemicals (TICs) that is...izing odors. This sensor array could be useful in...
(Date:11/18/2009)...alif., Nov. 18 Sangamo B...that data from the University of Pennsylvania inve...,s zinc finger nuclease (ZFN) based product, SB-72...ly disclosed on the internet. ,, Data were pres...nsylvania School of Medicine from a single subject...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
... An air impaction microbial assessment of yo...abitants,in your compressed air system, ...RODUCTION, , Manufacturers of ... may use compressed,air in various applications.... of conveyor belts,and/or aseptic cleaning proc...
... Part I - E. col , , ...fic Co., Inc., , , The ...res for carrying out a benchtop fermentation,pa...n a,question and answer format, this article cov...g size, and,concentration of various additives s...
...this BioPharm,International exclusive,interv...,manufacture of his,companys innovative,cancer....Zhaohui Peng is the chairman,chief executive off..., Ltd., , Langshen Road, Shenzhen Hi-Tech....2696.8818, , fax: 0755.2696.8808, , ...
Other Biology Technology:Testing Compressed Air Lines for Microbiological Contamination 2Testing Compressed Air Lines for Microbiological Contamination 3Testing Compressed Air Lines for Microbiological Contamination 4Testing Compressed Air Lines for Microbiological Contamination 5Testing Compressed Air Lines for Microbiological Contamination 6Testing Compressed Air Lines for Microbiological Contamination 7Fundamentals of Fermentation: Techniques For Benchtop Fermentors 2Fundamentals of Fermentation: Techniques For Benchtop Fermentors 3Fundamentals of Fermentation: Techniques For Benchtop Fermentors 4Fundamentals of Fermentation: Techniques For Benchtop Fermentors 5Fundamentals of Fermentation: Techniques For Benchtop Fermentors 6Fundamentals of Fermentation: Techniques For Benchtop Fermentors 7Fundamentals of Fermentation: Techniques For Benchtop Fermentors 8Fundamentals of Fermentation: Techniques For Benchtop Fermentors 9Fundamentals of Fermentation: Techniques For Benchtop Fermentors 10Fundamentals of Fermentation: Techniques For Benchtop Fermentors 11Fundamentals of Fermentation: Techniques For Benchtop Fermentors 12Fundamentals of Fermentation: Techniques For Benchtop Fermentors 13Fundamentals of Fermentation: Techniques For Benchtop Fermentors 14Fundamentals of Fermentation: Techniques For Benchtop Fermentors 15Fundamentals of Fermentation: Techniques For Benchtop Fermentors 16Fundamentals of Fermentation: Techniques For Benchtop Fermentors 17Fundamentals of Fermentation: Techniques For Benchtop Fermentors 18Fundamentals of Fermentation: Techniques For Benchtop Fermentors 19The Genesis of Gendicine: The Story Behind the First Gene Therapy 2The Genesis of Gendicine: The Story Behind the First Gene Therapy 3The Genesis of Gendicine: The Story Behind the First Gene Therapy 4The Genesis of Gendicine: The Story Behind the First Gene Therapy 5The Genesis of Gendicine: The Story Behind the First Gene Therapy 6The Genesis of Gendicine: The Story Behind the First Gene Therapy 7The Genesis of Gendicine: The Story Behind the First Gene Therapy 8The Genesis of Gendicine: The Story Behind the First Gene Therapy 9The Genesis of Gendicine: The Story Behind the First Gene Therapy 10The Genesis of Gendicine: The Story Behind the First Gene Therapy 11The Genesis of Gendicine: The Story Behind the First Gene Therapy 12
(Date:11/22/2009)...renatally to tobacco smoke and during childhood to...rding to research done at Cincinnati Children,s Ho...t up to 35 percent of ADHD cases in children betwe...ating both of these environmental exposures. This ...Tobacco and lead exposure each have their own impo...
(Date:11/22/2009)...09 Agios Pharmaceuticals today announced that its...that the mutated IDH1 gene has a novel enzyme acti...ogene. This breakthrough discovery shows that the ...oxyglutarate (2HG), which may contribute to the fo...most common type of brain cancers. This discovery ...
(Date:11/20/2009)...d studies about the health benefits of having a li...r level, where amino acids known as cysteines are ...en paired up with other cysteines. , Now, resear...lleagues in Belgium, have discovered a new antioxi...search appears in the Nov. 20 issue of the journal...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Saving the single cysteine: New antioxidant system found 2Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010 12805 1Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010 12805 2Groups to Congress 3A Dont Sacrifice Patient Safety to Lower Health Costs 50184 1Groups to Congress 3A Dont Sacrifice Patient Safety to Lower Health Costs 50184 2Smoking May Trigger Brain Damage 50182 1Smoking May Trigger Brain Damage 50182 2
...rs have been mesmerized by the dazzling displays o...n tropical seas. Now researchers at Scripps Instit...ed key clues about the bioluminescent worms that p...s behind their light production. , Marine firewor...dersea mating ritual. Research conducted by Scripp...
...Butterflies seem able to both attract mates and wa...ngs, according to new research by Yale University ... these two crucial behaviors is one of nature,s ol...doctoral associate in Yale,s Department of Ecology...tudy, which appears online today in the journal P...
...ead and neck cancer patients who smoked, drank, di... were diagnosed had worse survival outcomes than t... study from the University of Michigan Comprehensi...t emphasis on biomarkers and genes that might be l...on has at diagnosis play a major role in his or he...
Other Biology News:Scripps scientists help decode mysterious green glow of the sea 2Sexy or repulsive? Butterfly wings can be both to mates and predators 2Health choices predict cancer survival, U-M study finds 2
Rabbit Anti-Human MMP-13 Collagenase-3, amino terminal end of active enzyme, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-BCAR1 Monoclonal Antibody, Unconjugated, Clone SPM302 from Abcam
Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents
Rabbit Anti-Myosin VIIa Polyclonal Antibody, Unconjugated from Abcam
Biology Products: